Merck seeks to impeach three Canadian patents, one composition patent and two formulation patents, belonging to Wyeth. The patents relate to a 13-valent pneumococcal polysaccharide protein conjugate vaccine commercialized under the name Prevnar® 13.

For the first time, the Federal Court and the Federal Court of Appeal were asked to review the Minister of Health’s application of Canada’s new patent term extension regime, known as Certificates of Supplementary Protection or CSPs.

Sea Tow Services International, Inc. (“Sea Tow”) appealed the outcome of summary non-use cancellation proceedings under Section 45 of the Trademarks Act (the “Act”) to amend its SEA TOW registrations to delete certain towing and on-water assistance services.

Apple Inc. (“Apple”) brought an ex parte motion for default judgment against Abdul Waseah operating as Mobile Q (“Mobile Q”).

This decision relates to an action commenced by Boulangerie Vachon Inc (“Vachon”) and its affiliates against Silvano Racioppo (the “Individual Defendant”) and companies for which he acts as principal, including Natural Stuff Inc. and Hostess Bread Company Inc. (collectively, the “Corporate Defendants”). In the action – which proceeded via summary trial in Federal Court – the Plaintiffs alleged infringement, passing off, and depreciation of goodwill in the HOSTESS trademark by the Defendants.

This decision concerned a motion by the plaintiff (PSET) to file reply expert reports in an ongoing patent infringement action. PSET argued that these reply reports were necessitated by new evidence introduced by the defendants’ (Google) responding expert reports.

The plaintiff [dTechs] was unsuccessful in its patent infringement action against the defendants British Columbia Hydro and Power Authority [BC Hydro] and Awesense Wireless Inc [Awesense]. It was held that the defendants had not infringed dTechs patent either individually or together, and that the patent was in any case invalid for obviousness and anticipation. This decision addressed the costs and disbursements payable by dTechs to the defendants as a result of this finding.

Merck Canada Inc (Merck) sought judicial review of the refusal by the Minister of Health (Minister) to add Canadian Patent No 2,830,806 (806 Patent) to the Patent Register pursuant to s 4(6) of the PM(NOC) Regulations. The Minister previously found that Merck’s patent lists were not submitted within the specified 30-day time period.

The Applicant, CAE Inc. (“CAE”) seeks to add Marc-André Proulx (“Mr. Proulx”) and Dac Toan Ho (“Mr. Ho”) as co-inventors to Canadian Patent No. 3,000,463 (the “463 Patent”), due to an inadvertent error or mistake pursuant to section 52 of the Patent Act.

Betser-Silevitch v. Petrochina Canada Ltd., 2021 FCA 76